Mark Sawicki - Mar 14, 2022 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Scientific Officer
Signature
/s/ Mark Sawicki
Stock symbol
CYRX
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
3/16/2022, 07:00 PM
Previous filing
Mar 11, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Award $0 +10.5K +20.35% $0.00 61.8K Mar 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Award $0 +20.9K $0.00 20.9K Mar 14, 2022 Common Stock 20.9K $29.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.
F2 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022.